US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Ongoing

Sterile Water for Injection USP

Reason Lack of Assurance of Sterility- Potential for fluid leakage from the port due to port misalignment.

B Braun Medical INC NDC 0264-7385-60 D-0652-2025
Class III · Low risk Ongoing

Kroger 70% Isopropyl Alcohol

Reason Cross Contamination with Other Products.

Consumer Product Partners, LLC D-0660-2025
Class II · Moderate risk Ongoing

Ultra Violette

Reason Subpotent/Super-potent Product: Testing of the SPF 50 sunscreen revealed inconsistency in SPF results ranging from SPF 4, 10, 21, 26, 33, 60, 61, and 64.

Grace & Fire Pty LTD NDC 84803-106-01 D-0640-2025
Class II · Moderate risk Ongoing

Sulfamethoxazole and Trimethoprim Tablets

Reason Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

Northwind Pharmaceuticals LLC NDC 51655-307-87 D-0654-2025
Class II · Moderate risk Ongoing

Carvedilol Tablets USP

Reason CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories NDC 0904-7307-61 D-0594-2025
Class III · Low risk Ongoing

Readyprep Pvp

Reason Subpotent drug

Medline Industries, LP NDC 53329-939-25 D-0674-2025
Class II · Moderate risk Completed

Dextroamphetamine Saccharate

Reason Presence of Foreign Tablet/Capsule: Two (2) bottles labeled as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10mg, 100ct, contained one (1) tablet of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 5 mg.

Lannett Company Inc. NDC 0527-0762-37 D-0642-2025
Class I · High risk Ongoing

Lactated Ringers's Injection USP

Reason Presence of Particulate Matter

B Braun Medical INC NDC 0264-7750-07 D-0627-2025
Class II · Moderate risk Ongoing

chlorproMAZINE Hydrochloride Tablets

Reason Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

Amneal Pharmaceuticals, LLC NDC 69238-1062-1 D-0619-2025
Class II · Moderate risk Ongoing

chlorproMAZINE Hydrochloride Tablets

Reason Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

Amneal Pharmaceuticals, LLC NDC 69238-1060-1 D-0618-2025
Class II · Moderate risk Ongoing

chlorproMAZINE Hydrochloride Tablets

Reason Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

Amneal Pharmaceuticals, LLC NDC 69238-1058-1 D-0617-2025
Class II · Moderate risk Ongoing

chlorproMAZINE Hydrochloride Tablets

Reason Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

Amneal Pharmaceuticals, LLC NDC 69238-1056-1 D-0616-2025
Class II · Moderate risk Ongoing

Sulfamethoxazole and Trimethoprim Tablets

Reason Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

Amneal Pharmaceuticals, LLC NDC 65162-272-10 D-0615-2025
Class II · Moderate risk Terminated

Lisdexamfetamine Dimesylate Capsules

Reason Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.

Lannett Company Inc. NDC 0527-4664-37 D-0599-2025
Class II · Moderate risk Ongoing

Duloxetine Delayed-Release Capsules

Reason CGMP deviations: N-nitroso-duloxetine impurity above the proposed interim limit.

Breckenridge Pharmaceutical, Inc. D-0621-2025
Class II · Moderate risk Ongoing

Theophylline extended-release tablets 400mg

Reason Failed Dissolution Specifications: Failure results (above) were reported for the Dissolution (by UV) test for commercial annual stability at the long-term shelf life stability interval, wherein the dissolution results do not comply with L3 stage dissolution criteria.

Glenmark Pharmaceuticals Inc., USA NDC 68462-380-01 D-0583-2025